REGN Exercise Disclosure
Zoghbi Huda Y · SEC Form 4 · Filed Nov 5, 2026
Exercise
Calculated transaction value
$2.83M
Zoghbi Huda Y Director
REGN
Transaction date
Nov 3, 2026
Public filing date
Nov 5, 2026
Filing lag
Filed 2 days later
REGN daily price context
Close on/before transaction
$973.36
Nov 3, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,439 shares @ $380.95
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001681643-26-000008
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$10.05M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN Current | Exercise | Nov 3, 2026 | $2.83M |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 3, 2026 | $6.73M |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 3, 2026 | $485.53K |
| Regeneron Pharmaceuticals, Inc. REGN | Exercise | Nov 3, 2026 | $0 |